Article
Impact of <sup>18</sup> FDG-avidity and immunosuppression on idiopathic and genetic cardiomyopathies
2026-02-03
Abstract excerpt
<h4>Background</h4> Myocardial 18 fluorodeoxyglucose ( 18 FDG)-avidity is frequently seen in patients with genetic cardiomyopathy (CMP), as well as a growing “idiopathic 18 FDG-avidity” group of genotype-negative patients who do not clearly have cardiac sarcoidosis (CS). <h4>Objectives</h4> To determine the prognostic implications of 18 FDG-avidity in patients with and without genetic CMP, and the effects o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cdbcdcd7-36a5-59d6-b7c4-a6db654040e2
- DOI
- 10.64898/2026.01.30.26345250
